Zhejiang Medicine Statistics

Total Valuation

Zhejiang Medicine has a market cap or net worth of CNY 13.86 billion. The enterprise value is 13.14 billion.

Market Cap	13.86B
Enterprise Value	13.14B

Important Dates

The next estimated earnings date is Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	Jul 10, 2024

Share Statistics

Zhejiang Medicine has 954.81 million shares outstanding. The number of shares has decreased by -1.09% in one year.

Shares Outstanding	954.81M
Shares Change (YoY)	-1.09%
Shares Change (QoQ)	-8.28%
Owned by Insiders (%)	0.34%
Owned by Institutions (%)	6.57%
Float	575.01M

Valuation Ratios

The trailing PE ratio is 29.41 and the forward PE ratio is 13.57.

PE Ratio	29.41
Forward PE	13.57
PS Ratio	1.68
PB Ratio	1.33
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.98, with an EV/FCF ratio of -200.39.

EV / Earnings	27.79
EV / Sales	1.59
EV / EBITDA	13.98
EV / EBIT	57.11
EV / FCF	-200.39

Financial Position

The company has a current ratio of 2.66, with a Debt / Equity ratio of 7.82.

Current Ratio	2.66
Quick Ratio	1.68
Debt / Equity	7.82
Debt / EBITDA	0.85
Debt / FCF	-12.22
Interest Coverage	16.52

Financial Efficiency

Return on equity (ROE) is 3.40% and return on invested capital (ROIC) is 1.31%.

Return on Equity (ROE)	3.40%
Return on Assets (ROA)	1.12%
Return on Capital (ROIC)	1.31%
Revenue Per Employee	1.33M
Profits Per Employee	75,913
Employee Count	6,227
Asset Turnover	0.65
Inventory Turnover	2.81

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +33.09% in the last 52 weeks. The beta is -0.06, so Zhejiang Medicine's price volatility has been lower than the market average.

Beta (5Y)	-0.06
52-Week Price Change	+33.09%
50-Day Moving Average	13.49
200-Day Moving Average	10.95
Relative Strength Index (RSI)	51.91
Average Volume (20 Days)	42,228,541

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Zhejiang Medicine had revenue of CNY 8.26 billion and earned 472.71 million in profits. Earnings per share was 0.49.

Revenue	8.26B
Gross Profit	2.67B
Operating Income	230.07M
Pretax Income	434.95M
Net Income	472.71M
EBITDA	926.20M
EBIT	230.07M
Earnings Per Share (EPS)	0.49

Full Income Statement

Balance Sheet

The company has 1.82 billion in cash and 801.20 million in debt, giving a net cash position of 1.02 billion or 1.07 per share.

Cash & Cash Equivalents	1.82B
Total Debt	801.20M
Net Cash	1.02B
Net Cash Per Share	1.07
Equity (Book Value)	10.24B
Book Value Per Share	10.88
Working Capital	3.54B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 591.24 million and capital expenditures -656.81 million, giving a free cash flow of -65.56 million.

Operating Cash Flow	591.24M
Capital Expenditures	-656.81M
Free Cash Flow	-65.56M
FCF Per Share	-0.07

Full Cash Flow Statement

Margins

Gross margin is 32.26%, with operating and profit margins of 2.78% and 5.72%.

Gross Margin	32.26%
Operating Margin	2.78%
Pretax Margin	5.26%
Profit Margin	5.72%
EBITDA Margin	11.21%
EBIT Margin	2.78%
FCF Margin	-0.79%

Dividends & Yields

This stock pays an annual dividend of 0.15, which amounts to a dividend yield of 1.03%.

Dividend Per Share	0.15
Dividend Yield	1.03%
Dividend Growth (YoY)	-11.76%
Years of Dividend Growth	n/a
Payout Ratio	40.43%
Buyback Yield	1.09%
Shareholder Yield	2.12%
Earnings Yield	3.40%
FCF Yield	-0.47%

Dividend Details

Stock Splits

The last stock split was on October 9, 2013. It was a forward split with a ratio of 1.8.

Last Split Date	Oct 9, 2013
Split Type	Forward
Split Ratio	1.8